A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study
| Status: | Terminated |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - 57 |
| Updated: | 4/21/2016 |
| Start Date: | December 2014 |
| End Date: | January 2015 |
A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871
Study is a multicenter, two-part, open-label phase II study in adults, evaluating the safety
and long-term efficacy of PF-06473871 one year after surgical revision and treatment with
PF-06473871.
and long-term efficacy of PF-06473871 one year after surgical revision and treatment with
PF-06473871.
Inclusion Criteria:
- Subjects previously randomized to Pfizer clinical study B5301001.
- Subjects must be able to tolerate up to a 3 hour scar revision surgery under sedation
and local anesthesia.
Exclusion Criteria:
- Pregnant female subject; breastfeeding female subjects; male subjects with partners
currently pregnant.
- Any previous history of intolerable adverse reactions to PF-06473871, such as serious
adverse events attributed to study drug or having been withdrawn due to AE in
prerequisite study B5301001.
We found this trial at
5
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials